Medicus Pharma Ltd. (MDCX)

NASDAQ: MDCX · Real-Time Price · USD

0.2801

-0.0739 (-20.88%)

At close: Aug 14, 2026, 4:00 PM EDT

0.2800

-0.0001 (-0.04%)

After-hours: Aug 14, 2026, 7:59 PM EDT

Medicus Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.17	8.71	4.16	1.72	0.27	0.08
Cash & Short-Term Investments	15.17	8.71	4.16	1.72	0.27	0.08
Cash Growth	56.93%	109.04%	142.21%	542.38%	240.90%	-
Prepaid Expenses	1.81	0.68	0.76	0.17	0.02	-
Other Current Assets	-	0.51	0.46	-	-	-
Total Current Assets	16.98	9.89	5.38	1.89	0.28	0.08
Property, Plant & Equipment	0.12	0.17	0.27	-	-	-
Total Assets	27.12	10.06	5.65	1.89	0.28	0.08

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.73	3.44	1.28	0.21	0.1	0.16
Accrued Expenses	0.47	1.11	0.91	0.4	-	-
Short-Term Debt	3.5	5.25	-	0.17	1.53	0.67
Current Portion of Leases	0.14	0.15	0.12	-	-	-
Other Current Liabilities	-	-	-	-	10.85	9.75
Total Current Liabilities	10.84	9.94	2.31	0.78	12.48	10.58
Long-Term Debt	18	0.03	-	-	-	-
Long-Term Leases	-	0.06	0.21	-	-	-
Total Liabilities	28.84	10.02	2.51	0.78	12.48	10.58

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	74.3	57.08	30.52	18.76	0.19	0.19
Additional Paid-In Capital	8.88	6.88	1.52	0.1	-	-
Retained Earnings	-85.01	-64.35	-28.9	-17.75	-12.39	-10.7
Comprehensive Income & Other	0.06	0.32	-	-	-	-
Total Common Equity	-1.76	-0.07	3.13	1.11	-12.2	-10.51
Minority Interest	0.04	0.1	-	-	-	-
Shareholders' Equity	-1.72	0.04	3.13	1.11	-12.2	-10.51
Total Liabilities & Equity	27.12	10.06	5.65	1.89	0.28	0.08

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	21.64	5.48	0.32	0.17	1.53	0.67
Net Cash (Debt)	-6.46	3.23	3.84	1.55	-1.26	-0.59
Net Cash Growth	-	-15.98%	147.33%	-	-	-
Net Cash Per Share	-0.19	0.19	0.40	0.45	-0.67	-0.18
Filing Date Shares Outstanding	60.17	39.36	11.82	8.08	6.43	3.22
Total Common Shares Outstanding	60.17	25.18	11.82	8.08	6.43	3.22
Working Capital	6.14	-0.05	3.07	1.11	-12.2	-10.51
Book Value Per Share	-0.03	-0.00	0.27	0.14	-1.90	-3.27
Tangible Book Value	-1.76	-0.07	3.13	1.11	-12.2	-10.51
Tangible Book Value Per Share	-0.03	-0.00	0.27	0.14	-1.90	-3.27

SEC Filings: 10-K · 10-Q